Molnupiravir 200 mg Suppliers & Bulk Manufacturers
Available Forms: Oral capsule
Available Strengths: 200 mg
Reference Brands: Lagevrio®(Us & EU)
Category: Anti Covid Medicines
Molnupiravir is an oral antiviral for mild to moderate COVID-19 in adults at risk of severe disease, taken as four 200 mg capsules every 12 hours for five days. The originator brand is Lagevrio (Merck, known as MSD outside the US and Canada). Indian companies have made generic molnupiravir under voluntary licences; we confirm the manufacturer, approvals and lead time for each order.
Manufacture or export Molnupiravir? List it or send an offer →
Product Description:
Molnupiravir is an oral antiviral. In the body it is converted to a nucleoside analogue that the virus builds into its RNA, causing so many copying errors that it can no longer replicate. It was developed by Ridgeback Biotherapeutics and Merck and is sold as Lagevrio. It received emergency use authorisation in the US in December 2021 and approval in the UK and a number of other countries, while in the EU the European Medicines Agency recommended against approval in 2023.
Molnupiravir manufacturing in India
In 2021 Merck signed voluntary licences with several Indian generic manufacturers, and also granted a licence through the Medicines Patent Pool (MPP), royalty-free while COVID-19 was a WHO public health emergency, that lets sublicensed makers supply 106 low- and middle-income countries. India's drug regulator authorised molnupiravir for restricted emergency use in December 2021, and many Indian brands followed.
Demand is far lower than in early 2022, so availability and lead time vary by manufacturer. Before you buy, check:
- Licence territory. Generic molnupiravir made under the Merck or MPP licences may be sold only in the countries those licences cover.
- Registration. Whether the product is registered or authorised in your market, or can be imported under a tender or emergency route.
- Documents and shelf life. The site's GMP certificate, a recent Certificate of Analysis, and the remaining shelf life on any stock offer.
Related antivirals on PharmaTradz include remdesivir. For hospital and government purchases see our tender supply service, or send us an RFQ with the quantity and destination market.
Molnupiravir — third party manufacturing & bulk supply
Molnupiravir 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Molnupiravir is supplied as Oral capsule — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Molnupiravir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Molnupiravir →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Several Indian companies were licensed by Merck in 2021, and a small number hold sublicences from the Medicines Patent Pool. We match your enquiry with licensed makers and confirm current availability and documents.
No. Generic molnupiravir made under the licences can be sold only in the countries they cover; the MPP licence lists 106 low- and middle-income countries. For other markets, check patent and registration status first.
It is supplied as 200 mg capsules. The adult dose is 800 mg (four capsules) every 12 hours for five days, started within five days of symptom onset.
In the US it is available under an emergency use authorisation rather than full approval. In the EU it is not authorised: the European Medicines Agency recommended refusal in 2023 and MSD withdrew its application.
Related Products
Favipiravir Tablet
Strength:
200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View Details
Tocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Remdesivir
Strength:
Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)
Form: Lyophilized powder for IV & Injection
Reference Brands: Veklury® (EU & US)
View Details
Nirmatrelvir / Ritonavir Tablet
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Baricitinib
Strength:
2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit
